骨软骨同种异体移植术的结局是否因年龄和性别而异?一项匹配组比较分析
该研究比较了年龄≥40岁与<40岁患者接受骨软骨同种异体移植术(OCA)后的临床结局,并分析性别差异。结果显示两组再手术率、失败率及患者报告结局评分均无显著差异,≥40岁组KOOS症状评分更高。男女结局总体相似,但失败时间在年龄亚组中存在性别差异。
要点
- 年龄≥40岁患者OCA术后再手术率、失败率与<40岁组无显著差异。
- 两组患者术后Lysholm、IKDC、KOOS、WOMAC、SF-12生理评分均较术前显著改善。
- ≥40岁组KOOS症状评分显著高于<40岁组(P=0.015)。
主要发现
- 共纳入170例患者(符合条件212例,随访率80.2%),平均随访5.0±2.7年(范围2.0-15.1年)。
- <40岁组115例(平均年龄27.6±7.3岁;男58例,女57例),≥40岁组55例(平均年龄44.9±4.0岁;男33例,女22例)。
- 两组再手术率无显著差异(<40岁组38% vs ≥40岁组36%,P=0.867),失败率无显著差异(<40岁组13% vs ≥40岁组16%,P=0.639)。
- 两组患者术后Lysholm、IKDC、KOOS、WOMAC、SF-12生理评分均较术前显著改善(均P<0.001)。
- ≥40岁组KOOS症状评分显著高于<40岁组(P=0.015);性别间并发症数、结局评分及失败时间无显著差异。
关键数值与推荐
- 失败定义为:翻修OCA、转为膝关节置换术或二次关节镜探查见移植物大体失败。
- 再手术率:<40岁组38% vs ≥40岁组36%(P=0.867)。
- 失败率:<40岁组13% vs ≥40岁组16%(P=0.639)。
- 再手术时间:<40岁组2.12±1.90年 vs ≥40岁组3.43±3.43年(P=0.126)。
- KOOS症状评分:≥40岁组显著高于<40岁组(P=0.015);<40岁组中女性失败显著快于男性(P=0.039),≥40岁组中男性失败显著快于女性(P=0.046)。
临床怎么用
- 作者认为OCA是年龄≥40岁患者骨软骨缺损的安全可靠治疗选择。
- 作者指出年轻患者术后KOOS症状评分较低可能与其功能恢复期望更高有关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The effect of patient age or sex on outcomes after osteochondral allograft transplantation (OCA) has not been assessed. PURPOSE: To determine clinical outcomes for male and female patients aged ≥40 years undergoing OCA compared with a group of patients aged <40 years. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: A review of prospectively collected data of consecutive patients who underwent OCA by a single surgeon with a minimum follow-up of 2 years was conducted. The reoperation rate, failure rate, and patient-reported outcome scores were reviewed. All outcomes were compared between patients aged <40 or ≥40 years, with subgroup analyses conducted based on patient sex. Failure was defined as revision OCA, conversion to knee arthroplasty, or gross appearance of graft failure at second-look arthroscopic surgery. Descriptive statistics, Fisher exact or chi-square testing, and Mann-Whitney U testing were performed, with P < .05 set as significant. RESULTS: A total of 170 patients (of 212 eligible patients; 80.2% follow-up) who underwent OCA with a mean follow-up of 5.0 ± 2.7 years (range, 2.0-15.1 years) were included, with 115 patients aged <40 years (mean age, 27.6 ± 7.3 years; 58 male, 57 female) and 55 patients aged ≥40 years (mean age, 44.9 ± 4.0 years; 33 male, 22 female). There were no differences in the number of pre-OCA procedures between the groups ( P = .085). There were no differences in the reoperation rate (<40 years: 38%; ≥40 years: 36%; P = .867), time to reoperation (<40 years: 2.12 ± 1.90 years; ≥40 years: 3.43 ± 3.43 years; P = .126), or failure rate (<40 years: 13%; ≥40 years: 16%; P = .639) between the older and younger groups. Patients in both groups demonstrated significant improvement in Lysholm (both: P < .001), International Knee Documentation Committee (IKDC) (both: P < .001), Knee Injury and Osteoarthritis Outcome Score (KOOS) (both: P < .001), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) (both: P < .001), and Short Form-12 (SF-12) physical (both: P < .001) scores compared with preoperative values. Patients aged ≥40 years demonstrated significantly higher KOOS symptom ( P = .015) subscores compared with patients aged <40 years. There were no significant differences in the number of complications, outcome scores, or time to failure between the sexes. In patients aged <40 years, female patients experienced failure significantly more quickly than male patients ( P = .039). In contrast, in patients aged ≥40 years, male patients experienced failure significantly more quickly than female patients ( P = .046). CONCLUSION: This study provides evidence that OCA is a safe and reliable treatment option for osteochondral defects in patients aged ≥40 years. Male and female patients had similar outcomes. Patients aged <40 years demonstrated lower KOOS symptom subscores postoperatively compared with older patients, potentially attributable to higher expectations of return to function postoperatively as compared with older patients.
引用
- Frank RM, Cotter EJ, Lee S, et al. Do Outcomes of Osteochondral Allograft Transplantation Differ Based on Age and Sex? A Comparative Matched Group Analysis. Am J Sports Med. 2017. PMID: 29140738. doi:10.1177/0363546517739625
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。